Specialty Drugs and Patients With Rare Diseases
In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people, with the total number of rare disease patients estimated to be 25 million to 30 million. While these diseases may be rare, the total number of people affected is large.
Because most individuals living with rare disease are between the ages of 18 and 65, commercial payers bear the largest share of the medical cost, while employers pay for significant productivity losses associated with absenteeism and presenteeism.
This includes productivity losses of $135 billion tied to adults with rare disease whose disease progression and diagnoses require time away from the workplace. For these reasons, a patient-first approach is critical.
Why Patient-First Works
Patient-first models deliver customized care coordination and telehealth solutions as an added layer that fosters discussion between the patient and pharmacist. This leads to a better understanding of the patient’s needs, focuses on the drug’s impact and monitors the patient’s overall health. By incorporating assessments and predetermined touch points each month, the care team is able to stay ahead of side effects and capture real-world evidence around the therapy, condition and patient’s well-being.
Patient-first care is effective because it includes targeted programs and services that deliver specialized expertise that goes well beyond the scope of capabilities provided by traditional, legacy care organizations that are simply built for scale.
In a world of shrinking options and technology, health insurance agents can highlight an approach that delivers the “human touch.” In fact, too often patients experience the retail pharmacy approach in which they are treated more as a daily quota, and not as someone facing an enormous life challenge.
This is where specialty pharmacists can play a significant role for patients and caregivers by providing an elevated level of customized care, helping caregivers optimize medication adherence, manage side effects and ensure that the patient feels heard to achieve the best possible quality of life and outcome.
Addressing Non-Clinical Issues
A patient-first approach prioritizes the needs of each patient, helping them and continually supporting them from day one and for their entire patient journey
Patient-first specialty pharmacists have gained in-depth knowledge on a range of rare diseases, allowing them to effectively collaborate with caregivers and patients. This enables physicians and specialists to focus more of their time on efficiently identifying appropriate therapies and developing long-term care plans. In turn, specialists treating these patients appreciate the additional insight, enhanced level of treatment and focus on streamlining communications.
Enlisting the help of a patient management organization that specializes in patient-first care coordination empowers healthcare professionals to focus on the patient experience through customized programs, services and specialized expertise that meets the needs of patients with rare diseases.
This added layer of disease-specific expertise also enables pharmacists to increase the caregiver’s understanding of the disease, which can help to further engage the patient in their treatment and promote optimal outcomes.
Ultimately, a patient-first approach offers a new strategy that health insurance agents can offer clients. Patient-first engages the entire care team to keep the patient’s overall health in mind with every decision, large or small, and leads to improved overall health and reduced economic burden.
Brandon Salke, Pharm.D., is the pharmacist-in-charge at Optime Care, a specialty pharmacy.
